Update zur bildgebenden Diagnostik bei Patienten mit Großgefäßvaskulitis

Zusammenfassung

Die Großgefäßvaskulitis umfasst die häufigere und oft bei älteren Patienten vorkommende Riesenzellarteriitis und die häufiger bei jüngeren Patientinnen auftretende Takayasu-Arteriitis. Die Bildgebung ist bei diesen Vaskulitiden sowohl für die Primärdiagnostik als auch bei Folgeuntersuchungen wichtig und wird im Folgenden differenziert dargestellt.

Abstract

Large vessel vasculitis (LVV) is an autoimmune disease subgroup that includes Giant cell arteritis (GCA) and Takayasu arteritis. The diagnosis of both is often challenging for the involved clinical specialties. The European League Against Rheumatism (EULAR) has proposed new recommendations with emphasis on the role of medical imaging for LVV diagnosis and follow-up, and suggests superseding of the longtime diagnostic reference standard surgical temporal artery biopsy in clear-cut GCA cases.

Schlüsselwörter

Großgefäßvaskulitis - Riesenzellarteriitis - Takayasu-Arteriitis - EULAR-Empfehlungen - Bildgebung

Key words

large vessel vasculitis - giant-cell arteritis - Takayasu arteritis - EULAR recommendations - imaging

• Literatur

• 1 Jennette J, Falk R, Bacon P. et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Curr Opin Rheumatol 2012; 65: 1-11
• 2 Smit E, Palmer AJ, Hewitt AW. Projected Worldwide Disease Burden from Giant Cell Arteritis by 2050. J Rheumatology 2014; 42: 119-125
• 3 Hunder GG, Bloch DA, Michel BA. et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122-1128
• 4 Muratore F, Kermani TA, Crowson CS. et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology 2015; 54: 463-470
• 5 Schmidt W, Seifert A, Gromnica-Ihle E. et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 2008; 47: 96-101
• 6 Berger CT, Sommer G, Aschwanden M. et al. The clinical benefit of imaging in the diagnosis and treatment of giant cell arteritis. Swiss Med Wkly 2018; 148: w14661
• 7 de Boysson H, Daumas A, Vautier M. et al. Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients. Autoimmun Rev 2018; 17: 391-398
• 8 Muto G, Yamashita H, Takahashi Y. et al. Large vessel vasculitis in elderly patients: early diagnosis and steroid-response evaluation with FDG-PET/CT and contrast-enhanced CT. Rheumatol Int 2014; 34: 1545-1554
• 9 Keser G, Aksu K, Direskeneli H. Takayasu arteritis: an update. Turk J Med Sci 2018; 48: 681-697
• 10 Hata A, Noda M, Moriwaki R. et al. Angiographic findings of Takayasu arteritis: New classification. Int J Cardiol 1996; 54: S155-S163
• 11 Origuchi T, Suzuki T, Nakashima Y. et al. AB0482 Takayasu arteritis and hla-b52 allele: a single-centre analysis from japanese population. Ann Rheum Dis 2013; 72: A936
• 12 Schmidt W, Kraft H, Vorpahl K. et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997; 337: 1336-1342
• 13 Stone JH, Tuckwell K, Dimonaco S. et al. Trial of Tocilizumab in Giant-Cell Arteritis. N Engl J Med 2017; 377: 317-328
• 14 Dejaco C, Ramiro S, Duftner C. et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018; 77: 636
• 15 Versari A, Pipitone N, Casali M. et al. Use of imaging techniques in large vessel vasculitis and related conditions. Q J Nucl Med Mol Imaging 2018; 62: 34-39
• 16 Duftner C, Dejaco C, Sepriano A. et al. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open 2018; 4: e000612
• 17 Slart R, Glaudemans A, Chareonthaitawee P. et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 2018; 45: 1250-1269
• 18 Geiger J, Bley T, Uhl M. et al. Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis. J Magn Reson Imaging 2010; 31: 470-474
• 19 Klink T, Bley TA. Herznahe Gefäße – Vaskulitis. In: Nikolaou K, Kramer U, Hafem A, Kreitner KF. Hrsg. Radiologische Differenzialdiagnostik Herz und große Gefäße. Stuttgart: Thieme; 2018: 537-551
• 20 Klink T, Geiger J, Both M. et al. Giant Cell Arteritis: Diagnostic Accuracy of MR Imaging of Superficial Cranial Arteries in Initial Diagnosis – Results from a Multicenter Trial. Radiology 2014; 273: 844-852
• 21 Veldhoen S, Klink T, Geiger J. et al. MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis. Eur Radiol 2014; 24: 2971-2979
• 22 de Boysson H, Liozon E, Lambert M. et al. 18F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients. Medicine (Baltimore) 2016; 95: e3851